Wolfe Research analyst Steve Fleishman lowered the price target on Abivax (NASDAQ: ABVX) to $136.00 (from $176.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE